Creatinine level

Eating red meat will boost creatinine levels. If you eat a lot of red meat for the 3 days prior to the test, your creatinine level will be normal, and the lab won t know that you ve diluted your urine sample. 

---

The older adult is more susceptible to the nephrotoxic effects of the cephalosporins particularly if renal function is already diminished because of age or disease. If renal impairment is present, a lower dosage and monitoring of blood creatinine levels are indicated. Bood creatinine levels greater than 4 mg/dL indicate serious renal impairment. In elderly patients with decreased renal function, a dosage adjustment may be necessary. 

Administration may result in nausea, vomiting, diarrhea, rash, anemia, leukopenia, and thrombocytopenia Signs of renal impairment include elevated blood urea nitrogen (BUN) and serum creatinine levels. Periodic renal function tests are usually performed during therapy. 

RISK FOR INEFFECTIVE TISSUE PERFUSION RENAL When the patient is taking a drag tiiat is potentially toxic to die kidneys, die nurse must carefully monitor fluid intake and output. In some instances, die nurse may need to perform hourly measurements of die urinary output. Periodic laboratory tests are usually ordered to monitor the patient s response to therapy and to detect toxic drag reactions. Seram creatinine levels and BUN levels are checked frequentiy during the course of therapy to monitor kidney function. If the BUN exceeds 40 mg dL or if the serum creatinine level exceeds 3 mg cIL, the primary health care provider may discontinue the drug therapy or reduce the dosage until renal function improves. 

Older adults are at increased risk for adverse reactions from the antineoplastic drugs because of the increased incidence of chronic disease, particularly renal impairment or cardiovascular disease. When renal impairment is present, a lower dosage of the antineoplastic may be indicated. Creatinine clearance isused to monitor renal function in the older adult. Blood creatinine levels are likely to be inaccurate because of a decreased muscle mass in the older adult. 

Other electrolytes of importance include calcium (especially if the patient is receiving a calcium channel blocker, such as nicardipine) and magnesium, as hypomagnesemia may predispose the patient to seizures, further complicating the ICP management. If the patient received intravenous iodinated contrast as part of their stroke evaluation, then careful monitoring of the blood urea nitrogen (BUN) and creatinine levels is necessary to detect contrast nephropathy. 

Obtain serum drug levels for aminoglycosides and/or vancomycin and perform pharmacokinetic analysis. Adjust the dose, if needed, according to the parameters in Table 13-2. Obtain follow-up trough levels at weekly intervals or sooner if renal function is unstable. Follow serum creatinine levels if renal function is unstable. Hearing tests may be scheduled yearly or per patient preference. 

Once the temperature is normal for 48 to 72 hours and the patient is eating, consider changing the IV antibiotic to an oral regimen for the duration of antibiotic treatment. Monitor the serum creatinine level to evaluate for renal complications as... 

Significant increases in serum urea nitrogen and serum creatinine levels (which may be indicative of impaired renal function) were observed in Pasteurella-infected rabbits exposed to 2,875 or 5,750 mg/kg/day of Fyrquel 220 for an intermediate duration (MacEwen and Vemot 1983). The results of the histological examination were not reported, and the renal effects of the infection were not discussed. 

Although determination of creatinine clearance rate is a standard clinical procedure, it is difficult to carry out mainly because accurate collection of total urine output over a 24-hour period is required. It can never be certain that this requirement has been met. Since creatinine is produced continuously in muscle and is cleared by the kidney, renal failure is characterized by elevated serum creatinine levels. The degree of elevation is directly related to the degree of renal failure—if it is assumed that the production of creatinine in the muscle mass is constant and that renal function is stable. When these assumptions are valid, there is a direct relationship between serum creatinine level and kanamycin half-life, as shown in Fig. 9. The equation of the line in Fig. 9 is... 

Thus, kanamycin half-lives (h) can be predicted in patients with varying degrees of (stable) renal failure by multiplying the serum creatinine level (in mg/lOOmL) by 3. 

The search for more potent, selective and safe PPARa agonists has been challenging and only a limited number of compounds have progressed into the clinic. A number of phenoxyacetic acid derivatives and other diverse structures have emerged recently. Oral administration of LY-518674 (6) produced a 208% elevation in HDL and a 96% decrease in serum TG in apoA-I transgenic mice [38,39]. Recent clinical studies with compound 6 revealed a decrease in TG and an increase in HDL similar to fenofibrate. However, compound 6 also raised LDL-C in a dose-dependent fashion, and to a much higher level than seen with fenofibrate [28]. Both agents also raised serum creatinine levels above the upper limits of normal in 35-38% of patients [28]. 

Creatinine is a metabolic breakdown product of muscle and usually has a constant value in an individual. Its value ranges from 0.6 mg/100 mL of serum to 1.2 mg/100 mL of serum. Creatinine is almost exclusively eliminated by the kidneys. Therefore, if the level of creatinine increases in the serum, it is likely that the capability of kidneys to eliminate the drugs is reduced. As a general rule, if the serum creatinine level (Ccr) is doubled, the kidney function is one-half. If the Ccr is quadrupled, the renal (kidney) function is one-fourth or 25%. 

A method for estimating the prognosis in individual cases was recently proposed by Holmendahl the Cortinarius Nephro Toxicity (CNT) Prognosis Index. This test is based on the serum creatinine level before treatment (y) and the number of days elapsed (X) ... 

In another study, hyaline droplets were detected in the kidneys of two male rats that died 48 hours after a single exposure to 47,280 mg/kg JP-5 by gavage (Parker et al. 1981). This effect was not apparent in male rats that died within 48 hours of exposure to 47,280 mg/kg or in rats that survived for 14 days following exposures to 18,912-37,824 mg/kg JP-5. However, hyaline droplets were apparent in rats that were killed within 2-3 days of exposure to 18,912 mg/kg JP-5. Thus, the effect appears to be induced within a specific period, between 2 and 14 days, following exposure. A single exposure to 18,912 mg/kg JP-5 also induced a statistically significant increase in creatinine levels (Parker et al. 1981). These effects are apparently unique to male rats and are not expected to occur in humans (see discussion in Section 2.2.1.2 under Renal Effects). 

Renal Effects. Acute renal failure occurred in a man who washed his hair with an unknown amount of diesel fuel (Barrientos et al. 1977). In addition, he had oliguria biopsy revealed mitosis and vacuolization in renal cells, tubular dilation, and some cellular proliferation in the glomerulus. Another man developed acute tubular renal necrosis after washing his hands with an unspecified diesel fuel over several weeks (Crisp et al. 1979). Specifically, patchy degeneration and necrosis of the proximal and distal tubular epithelium with preservation of the basement membranes were noted. Also, increased blood urea nitrogen and serum creatinine levels were noted in this individual. Effects resulting from inhalation versus dermal exposure could not be distinguished in these cases. 

Monitoring Periodic routine CBCs (including platelet count), serum creatinine level, and stool occult blood tests are recommended during the course of treatment. 

Renal disease or renal dysfunction (eg, as suggested by serum creatinine levels greater than or equal to 1.5 mg/dL [males], greater than or equal to 1.4 mg/dL [females], or abnormal Ccr) that may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction (Ml), and septicemia CHF requiring pharmacologic treatment hypersensitivity to metformin acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Treat diabetic ketoacidosis with insulin. 

Renal function impairment Metformin is known to be excreted by the kidney, and the risk of metformin accumulation and lactic acidosis increases with the degree of impairment of renal function. Do not give metformin to patients with serum creatinine levels above the upper limit of normal for their age. 

Hyperkalemia The principal risk of epierenone is hyperkalemia. Hyperkalemia can cause serious, sometimes fatal arrhythmias. This risk can be minimized by patient selection, avoidance of certain concomitant treatments, dose reduction of epierenone, and monitoring. The rates of hyperkalemia increase with declining renal function. Treat patients with CHF post-MI who have serum creatinine levels greater than 2 mg/dL (males) or greater than 1.8 mg/dL (females), patients who have Ccr 50 mL/min or less, and diabetic patients with CHF post-MI, including those with proteinuria, with caution. 

High concentrations of cefoxitin (greater than 100 mcg/mL) may interfere with measurement of creatinine levels by the Jaffe reaction and produce false results. Cefotetan may also affect these measurements. 

Rule of eights Approximate the interval between doses (in hours) by multiplying the serum creatinine level (mg/dL) by 8. For example, a patient weighing 60 kg with a serum creatinine level of 2 mg/dL could be given 60 mg (1 mg/kg) every 16 hours (2 x 8). 

Renal function impairment In patients with moderate or severe renal insufficiency (Ccr below 50 mL/min), accumulation of the IV vehicle, SBECD, occurs. Administer oral voriconazole to these patients, unless an assessment of the benefit/risk to the patient justifies the use of IV voriconazole. Closely monitor serum creatinine levels in these patients, and, if increases occur, consider changing to oral voriconazole therapy. 

Increased serum creatinine levels have been observed in trials evaluating valganciclovir tablets. Patients should have serum creatinine or Ccr values monitored carefully to allow for dosage adjustments in renally impaired patients. The mechanism of impairment of renal function is not known. 

Renal - Methotrexate may cause renal damage that may lead to acute renal failure. Close attention to renal function including adequate hydration, urine alkalinization and measurement of serum methotrexate and creatinine levels are essential for safe administration. 

---